StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Other Medicines (Established / Legacy Brands) by Quarter

Other Medicines (Established / Legacy Brands) — US product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Other Medicines (Established / Legacy Brands): $19M in Q2 2026, down 9.5% from a year earlier.

Latest, Q2 2026
19
Period ended Jun 30, 2026
Change on a year earlier
-9.5%
21 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Other Medicines | | 230 | | ( 4 ) | | ( 6 ) | | 19 | | ( 9 ) | | 166 | | ( 10 ) | | ( 13 ) | | 25 | | 52 | | 51 | | 20 | | 12 | | 14”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Therapy Area Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Medicines (Established / Legacy Brands) — US product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202619-9.5%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202623+21.1%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202514-41.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20259-74.3%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202521-25.0%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202519-20.8%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202424-17.2%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202435-2.8%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202428-12.5%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202424-33.3%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 202329-9.4%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202336-2.7%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202332-11.1%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202336-7.7%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202232-22.0%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202237-53.7%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up other Medicines (Established / Legacy Brands)

Cite this data

StockData. (2026). AstraZeneca Other Medicines (Established / Legacy Brands) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-other-meds-us

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.